# Biomat USA, Inc. – FDA Inspection, Jul 25, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/88ee4c1e-d39e-4966-bb4c-e447d6a7f126
Source feed: FDA_Inspections

> FDA inspection 1059921 of Biomat USA, Inc., July 25, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059921
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-07-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1252470 - 2025-02-27
- FDA Inspection 872475 - 2014-03-19
- [FDA Inspection 740512 - 2011-08-22](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/432d2c58-24cf-48b2-a255-662a58a79648)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/charles-d-boison/b128f4a3-c1b1-409f-9291-27deb111d1e5)

Company: https://www.keypedia.com/companies/biomat-usa-inc/16ebf1f3-9d78-41cd-8f11-36b043b1ec88

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d